| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 03/17/2004 | EP1398166A1 Ink jet recording material and light-stabilising agent |
| 03/17/2004 | EP1397349A1 4-imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators |
| 03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/17/2004 | EP1397327A2 DEUTERATED N-SUBSTITUTED AND $g(a)-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
| 03/17/2004 | EP1242406B1 Novel compounds |
| 03/17/2004 | EP1240140B1 Method for the production of n-alkenyl amides |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | EP1140839B1 Heterocyclic amides as inhibitors of factor xa |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders |
| 03/17/2004 | CN1483025A Chemical compounds |
| 03/17/2004 | CN1142141C Ethanesulfonyl-piperidine derivatives |
| 03/17/2004 | CN1142138C Preparation of thiol-carbamate and sulfocyanic ester compound |
| 03/17/2004 | CN1141936C Usage of aryl-cyclohexylamine derivative in anti-disorder of central nervous system |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706745 Biphenylamidine derivatives |
| 03/16/2004 | US6706735 Nitrogen compounds such as n-(3-(4-benzyl-2-piperidinyl)propyl )-n'-(3-cyanophenyl)urea, used as chemotactic cytokine controllers administered for prophylaxis of asthma, allergies and autoimmune diseases |
| 03/16/2004 | US6706734 Antiischemic agents; anticonvulsants; headaches |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/11/2004 | WO2004020412A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 03/11/2004 | WO2004020411A1 Naphthamide derivatives and their use |
| 03/11/2004 | WO2004020410A2 Dihydropyridinone derivatives as hne inhibitors |
| 03/11/2004 | WO2004020401A1 Synthesis of sulfonamide derivatives |
| 03/11/2004 | WO2004019942A1 Inverse agonists acting at virus-encoded g protein-coupled receptors |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | WO2003009845A9 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/11/2004 | WO2003006444A3 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 03/11/2004 | WO2002102743A9 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
| 03/11/2004 | US20040049043 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049030 Such as naphthalenes, anthracenes, phenanthrenes, tetracenes, perylenes, terrylenes, quaterrylenes, pentarylenes, hexarylenes, anthraquinones, indanthrones, and N-substituted naphthalene-1,8-dicarboxylic monoimides |
| 03/11/2004 | US20040048904 E.g., 1-(pyridin-4-ylcarbamoyl)-1,2,3,6- tetrahydropyridine hydrochloride; treating and/or preventing amnesia or dementia |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048893 Hydrolysis and decarboxylation of 1-alkyl- or aralkyl-4-((2-hydrocarbyloxycarbonyl-5,6-dimethoxyindan-1-one)-2 -yl)methylpiperidine |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048856 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | US20040048851 Amidinophenylalanine derivatives as thrombin inhibitors |
| 03/11/2004 | US20040048848 Novel gamma secretase inhibitors |
| 03/11/2004 | US20040048832 Compounds useful in preparing camptothecin derivatives |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/10/2004 | EP1396490A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives |
| 03/10/2004 | EP1395576A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395575A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395574A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395560A1 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders |
| 03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395557A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395556A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395555A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481363A N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as polymerisation in hibitors |
| 03/10/2004 | CN1481362A New process for prepn. diaryl-4-amino-piperidinyl compounds |
| 03/10/2004 | CN1481361A Piperidine MCH antagonists and their use in treatment of obesity |
| 03/10/2004 | CN1481360A 蕈毒碱拮抗剂 Muscarinic antagonist |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 03/10/2004 | CN1480453A Compound of fluorene class containing dual hetero atoms as well as its synthetic method and application |
| 03/10/2004 | CN1480139A Local medical compsn contg cholinergic medicine or calcium passage retardant |
| 03/10/2004 | CN1141297C Process for preparing amlodiping benzenesulphonate |
| 03/10/2004 | CN1141296C 4-amino piperdine synthesizing and catalyst and preparation process thereof |
| 03/09/2004 | US6703508 Analgesics |
| 03/09/2004 | US6703408 N-formyl derivatives of paroxetine |
| 03/09/2004 | US6703406 Treatment of nervous system, psychological, and eating disorders; drug abuse, drug dependence |
| 03/09/2004 | US6703383 Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/04/2004 | WO2004018644A2 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 03/04/2004 | WO2004018442A1 Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | WO2004018426A1 Organic acid salt of amlodipine |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018424A1 Thin display device |
| 03/04/2004 | WO2004018423A1 New benzoyl piperidine compounds |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004017970A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 03/04/2004 | WO2004017969A1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
| 03/04/2004 | WO2003053326A3 Enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; its pharmaceutical compositions and processes of making them |
| 03/04/2004 | WO2003045878A3 2,w-diaminocarboxylic acid compounds |
| 03/04/2004 | WO2003024928A3 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/04/2004 | US20040044218 Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate |
| 03/04/2004 | US20040044215 Crystallization, filtration; neurokinins receptor antagonist |
| 03/04/2004 | US20040044202 Functionalized monomers for synthesis of rubbery polymers |
| 03/04/2004 | US20040044157 Functionalized monomers for synthesis of rubbery polymers |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040044039 Antiemetic compositions of optically pure (+) norcisapride |
| 03/04/2004 | US20040044038 Polymorphic form XVI of fexofenadine hydrochloride |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 03/04/2004 | US20040044033 Cognition activators; psychological disorders; central nervous system disorders |
| 03/04/2004 | US20040044017 Tetrahydropyridines |
| 03/04/2004 | US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders |
| 03/04/2004 | US20040044004 Calcium channel inhibitors comprising benzhydril spaced from piperazine |